Latest News & Features
Americas
Despite the headwinds facing the industry, a growing number of leading pharmaceutical companies feature on Thomson Reuters’ annual Top 100 Global Innovators list, as Bob Stembridge reports. 30 January 2015
Americas
Existing portfolios should be carefully reviewed and care must be taken in drafting new patent applications to withstand section 101 scrutiny in the US, as Judith Kim, director, and Scott Schaller, of counsel, at Sterne Kessler Goldstein & Fox, describe. 30 January 2015
Americas
The most recent Illicit Trade Report states that pharmaceuticals are by far the most numerous counterfeit commodity reported, and the problem is increasing. LSIPR investigates what’s being done about it. 30 January 2015
Americas
Drug companies Gilead and Mylan are expanding their licensing agreement covering hepatitis C treatment to include two new products. 29 January 2015
Big Pharma
US pharmaceutical company Pfizer has reported that last year it saw a drop in sales revenue and has blamed it on the loss of certain important patents. 29 January 2015
Americas
A group of health organisations has urged US President Barack Obama to support India as a provider of low-cost generic medicines around the world. 28 January 2015
Americas
Generic drug makers Sandoz, Mylan and Natco have asked the US Supreme Court to immediately put into effect its ruling on the validity of a patent covering Teva’s multi-billion dollar multiple sclerosis drug Copaxone. 27 January 2015
Americas
Genetic diagnostic companies Myriad Genetics and Pathway Genomics have settled their patent dispute involving BRCA gene testing. 27 January 2015
Americas
The US Supreme Court has sent back three patent cases to the US Court of Appeals for the Federal Circuit for further consideration following its ruling on Teva v Sandoz last Tuesday. 27 January 2015
Americas
The US Court of Appeals for the First Circuit has upheld class certification in the Nexium pay-for-delay case. 26 January 2015